AU000000TLX2
AU000000TLX2
TELIXPHARM FPO [TLX]
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 803.794.000 | 516.551.000 | 55.6% |
| Cost of Revenue | 377.356.000 | 180.388.000 | 109.2% |
| Gross Profit | 426.438.000 | 336.163.000 | 26.9% |
| 408.385.000 | 280.579.000 | 45.6% | |
| Operating Income | 18.053.000 | 55.584.000 | 67.5% |
| Pretax Income | -5.266.000 | 37.915.000 | 113.9% |
| Net Income Common Stockholders | -7.125.000 | 33.685.000 | 121.2% |
| -- | -- | -- | |
| -- | -- | -- |